Suvretta Capital Management, LLC Prometheus Biosciences, Inc. Transaction History

Suvretta Capital Management, LLC

  • $2.54 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$22.28 - $39.54 $10.7 Million - $19 Million
-480,480 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$20.89 - $26.96 $3.03 Million - $3.91 Million
-145,145 Reduced 23.2%
480,480 $11.4 Million
Q2 2021

Aug 16, 2021
BUY
$16.8 - $29.65 $791,128 - $1.4 Million
47,091 Added 8.14%
625,625 $15.4 Million
Q1 2021

May 17, 2021
BUY
$16.51 - $25.29 $9.55 Million - $14.6 Million
578,534 New
578,534 $10.6 Million

Others Institutions Holding RXDX

# of Institutions
2
Shares Held
29.6K
Call Options Held
0
Put Options Held
0
View Full List

About Prometheus Biosciences, Inc.

RXDX Quotes by TradingView
  • Ticker RXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,904,100
  • Description
  • Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial...
More about RXDX
Track This Portfolio

Track Suvretta Capital Management, LLC Portfolio

Follow Suvretta Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Suvretta Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Suvretta Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email